21 Jun 2021 --- The European Food Safety Authority (EFSA) has rejected Nestlé’s claim request relating to the ability of one of its infant formulas to reduce the risk of developing atopic dermatitis (AD) in infants. This comes just two months after EFSA also refuted a beta-glucan-based health claim from Nestlé – the Swiss food giant’s first EU health claim submission since 2010.
